(Q35176981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Christopher S. Williams

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

D Scott Smith

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Christopher D Ferris

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterology Clinics of North America

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

619-658

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

Intestinal pseudo-obstruction

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Review article: the pharmacological treatment of acute colonic pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Acute colonic pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Acute Intestinal Pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Role and integration of mechanisms controlling gastric emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Role of caloric content on gastric emptying in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

A migrating electric complex of canine small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal symptoms in middle-aged diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Natural history of diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hyperglycaemia stimulates pyloric motility in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Electrical arrhythmias in the human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of diabetes on relaxations to non-adrenergic, non-cholinergic nerve stimulation in longitudinal muscle of the rat gastric fundus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

13C-octanoic acid breath test for gastric emptying measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

A valid, accurate, office based non-radioactive test for gastric emptying of solids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

13C mixed triglyceride breath test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Comparison of the Barium Test Meal and the Gamma Camera Scanning Technic in Measuring Gastric Emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Electrogastrography in patients with gastroparesis and effect of long-term cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Electrogastrography: current issues in validation and methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Measurement by epigastric impedance of gastric emptying in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastric emptying in patients with type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Serum glucose concentration as a modulator of interdigestive gastric motility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Exercise increases solid meal gastric emptying rates in men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of exercise on postprandial gastric secretion and emptying in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastric emptying during walking and running: effects of varied exercise intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Metoclopramide: pharmacology and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Diabetic gastroparesis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal Effects of Metoclopramide in Man. In Vitro Experiments with Human Smooth Muscle Preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Management of the patient with gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastric emptying disorders. Clinical significance and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Metoclopramide-induced movement disorders. Clinical findings with a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: an eight-week double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Cisapride vs metoclopramide. An acute study in diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic metoclopramide therapy for diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Motility-modifying agents and management of disorders of gastrointestinal motility.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Receptor for motilin identified in the human gastrointestinal system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of erythromycin on gastroduodenal contractile activity in developing neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Erythromycin accelerates solid emptying at the expense of gastric sieving

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Erythromycin-induced cardiac toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Erythromycin improves glycaemic control in patients with Type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The brute force approach to electrical stimulation of gastric emptying: A future treatment for refractory gastroparesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of leucine 13-motilin (KW5139) on early gastric stasis after pylorus-preserving pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Long-term efficacy of cisapride in diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Contraindicated use of cisapride: impact of food and drug administration regulatory action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Domperidone: a peripherally acting dopamine2-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

On the pharmacokinetics of domperidone in animals and man. I. Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Lack of effect of domperidone on gastrin release: evidence for a peripheral activity of the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Percutaneous endoscopic gastrostomy and gastrojejunostomy: a critical reappraisal of patient selection, tube function and the feasibility of nutritional support during extended follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Completion gastrectomy for postsurgical gastroparesis syndrome. Preliminary results with 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastroparesis cured by gastrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Surgical therapy of diabetic gastroparesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of electrical stimulation on gastric electrical activity, motility and emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Human gastric myoelectric activity and gastric emptying following gastric surgery and with pacing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal functional bowel disorders: new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of electrical stimulation on acupuncture points in diabetic patients with gastric dysrhythmia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Botulinum toxin for the treatment of gastroparesis: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Cholecystokinin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effects of sildenafil on esophageal motility of patients with idiopathic achalasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hirschsprung disease, associated syndromes, and genetics: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Pseudo-obstruction: current approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Gastrointestinal motility in neonatal and pediatric practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Motility Disorders in Childhood: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Intestinal pseudoobstruction caused by a new form of visceral neuropathy: palliation by radical small bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic intestinal pseudo-obstruction: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Subtotal colectomy for severe idiopathic constipation. A follow-up study of 13 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane's disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Small cell lung cancer with positive anti-Hu antibodies presenting as gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Paraneoplastic dysmotility: loss of interstitial cells of Cajal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Small-intestinal mucosa in pseudoobstruction syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Relationship between impaired gastric emptying and abnormal gastrointestinal motility.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Antroduodenal motility in children with chronic intestinal pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Oesophageal manometry in the evaluation of megacolon with onset in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The enteric nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic intestinal pseudo-obstruction in infants and children caused by diverse abnormalities of the myenteric plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Neuropathology of the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Abnormal distribution of the interstitial cells of cajal in an adult patient with pseudo-obstruction and megaduodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Involvement of endogenous nitric oxide and c-kit-expressing cells in chronic intestinal pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Intractable constipation with a decrease in substance P-immunoreactive fibres: is it a variant of intestinal neuronal dysplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Neostigmine increases postoperative colonic motility in patients undergoing colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Review article: tegaserod

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic intestinal pseudo-obstruction. Management with total parenteral nutrition and a venting enterostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Current results of intestinal transplantation. The International Intestinal Transplant Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Myenteric plexus in congenital megacolon; study of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hirschsprung's disease; a new concept of the etiology; operative results in 34 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Chronic intestinal pseudo-obstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Acetylcholinesterase activity in suction biopsies of the rectum in the diagnosis of Hirschsprung's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Hirschsprung's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Enteric nervous system: development and developmental disturbances--part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Enteric nervous system: development and developmental disturbances--part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

The GDNF/RET signaling pathway and human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Small bowel transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Intestinal transplantation. Experience in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Immunocytochemical characterization of supporting cells in the enteric nervous system in Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

An immunochemical study with neuron-specific-enolase and substance P of human enteric innervation--the normal developmental pattern and abnormal deviations in Hirschsprung's disease and pyloric stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Interstitial cells of Cajal in human gut and gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

RET mutations in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

Loss of function effect of RET mutations causing Hirschsprung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

SOX10 mutations in patients with Waardenburg-Hirschsprung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2803%2900028-1

7 January 2021

10.1016/S0889-8553(03)00028-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858609%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference